Newspaper Advertisement of the Unaudited Financial Result for the Quarter and half year ended on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals Ltd has published its unaudited standalone financial results for the quarter ended 30 September 2025 via newspaper advertisements in Financial Express and Mumbai Lakshdeep. Total income from operations rose to Rs. 238.50 lakhs in Q2 FY26, up about 39% from Rs. 171.44 lakhs in the same quarter last year. Profit before tax and profit after tax both stood at Rs. 12.56 lakhs, roughly three times the Rs. 3.99 lakhs earned in Q2 FY25. Basic and diluted EPS came in at Rs. 0.27 versus Rs. 0.09 a year ago. Equity share capital remained Rs. 460 lakhs (face value Rs. 10). The full-year FY25 results had shown a loss of Rs. 71.83 lakhs, making this quarter a return to profit. Results were approved by the Board on 14 November 2025 and filed with BSE under SEBI LODR Regulation 33.
The company has swung back to profit after reporting a full-year loss in FY25, which is a positive signal for shareholders, though the absolute earnings remain small given its modest revenue base. This is mainly a compliance disclosure and is unlikely to move the stock significantly on its own.